NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTCBB: XKEM), Dr. Ramesh Pandey, president and CEO of Xechem International, was interviewed at length by United Press International (UPI) recently on his plans to manufacture and market the first new treatment for Sickle Cell Disease in decades in Nigeria. Sickle Cell Disease threatens the lives of 4 million Nigerians, as well as 80,000 Americans and many millions more worldwide.
